This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Innovations by David Vanhoute
Introduction
David Vanhoute is an accomplished inventor based in Troy, NY (US). He has made significant contributions to the field of viral contamination detection, holding a total of 4 patents. His work is particularly relevant in the context of public health and safety.
Latest Patents
One of his latest patents is titled "Systems and methods for identifying viral contaminants." This patent introduces a streamlined sample preparation process known as VERA (Viral Enrichment by Reducing Artifacts). The process aims to tilt total genomic material in favor of DNA/RNA viral genomes, significantly reducing host genomic artifacts. This reduction can be completed in less than eight hours from sample acquisition. Additionally, using a rapid library preparation protocol of approximately 1.5 minutes and real-time nanopore sequencing, potential viral contamination, such as RNA viral contamination, can be identified in less than one workday from sample acquisition. Another notable patent is a "Support for test device," which describes a support holder designed for a test device. This holder includes a base with a unique configuration of sidewalls and projections, allowing for effective support and functionality.
Career Highlights
David Vanhoute is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate and contribute to advancements in biotechnology. His work has been instrumental in developing methods that enhance the detection of viral contaminants, which is crucial for various applications in health and safety.
Collaborations
David has collaborated with notable colleagues, including Christopher Hunter and Steven Davis. Their combined expertise has likely contributed to the success of their projects and innovations.
Conclusion
David Vanhoute's contributions to the field of viral contamination detection through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his role as a significant innovator in biotechnology. His advancements are paving the way for improved health safety measures.